← Open Payments lookup

ERIKA MULLEN: Open Payments

NPI 1306008065 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$363 in 18 payments from 7 companies in 2025. Trend: 2023 $250 · 2024 $444 · 2025 $363

Food & beverage: $363
CompanyPaymentsAmount
GENZYME CORPORATION3$76
Novartis Pharmaceuticals Corporation3$69
Regeneron Healthcare Solutions, Inc.3$55
AstraZeneca Pharmaceuticals LP3$51
GlaxoSmithKline, LLC.2$50
Amgen Inc.3$43
ARS Pharmaceuticals Operations, Inc.1$19

Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Rhapsido, NEFFY.

Industry payments across TX — which companies pay providers there.